Pandemic influenza A/H1N1 and organ donation.
One of the concerns regarding the pandemic of novel influenza A/H1N1 virus is its potential to hamper transplant programs if the decision is made that organs from donors with influenza A/H1N1 should not be used. Evidence of transmissibility through organ transplantation is speculative at best. We report the outcome of 2 kidney transplant recipients who received kidneys from the same deceased donor, in whom the diagnosis of infection by the novel virus became available only after engraftment. The donor also had received a complete course of antiviral treatment before donation. The recipients were transplanted at 2 different facilities and were managed differently. Neither recipient developed flu syndrome, and both had an uneventful outcome. It is possible to speculate that kidneys from donors who have had confirmed influenza A/H1N1 and who have received antiviral treatment can be safely used in transplantation.
Lattes
R
R
Department of Transplantation, Infectious Disease Section, Instituto de Nefrología, Cabello, Buenos Aires, Argentina. robertalattes@datamarkets.com.ar
Jacob
N
N
de la Fuente
J
J
Fragale
G
G
Massari
P
P
D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D004196:Disease Outbreaks; D005260:Female; D014943:Global Health; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome
D000998:Antiviral Agents